Philip Hoflinger
Siegfried Weller Research Institute At The BG Unfallklinik Tübingen, Schnarrenbergstr. 95
Tuebingen, BW 72076, Germany
Tuebingen, BW 72076, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Vitamin D3 deficiency and osteopenia in spastic paraplegia type 5 indicate impaired bone homeostasis.
Journal: Scientific reports
Published: July 24, 2023
Metabolic profiling in serum, cerebrospinal fluid, and brain of patients with cerebrotendinous xanthomatosis.
Journal: Journal of lipid research
Published: March 09, 2021
Deep mining of oxysterols and cholestenoic acids in human plasma and cerebrospinal fluid: Quantification using isotope dilution mass spectrometry.
Journal: Analytica chimica acta
Published: December 22, 2020
Generation of the CRISPR/Cas9-mediated KIF1C knock-out human iPSC line HIHRSi003-A-1.
Journal: Stem cell research
Published: August 12, 2020
Comparative Transcriptional Profiling of Motor Neuron Disorder-Associated Genes in Various Human Cell Culture Models.
Journal: Frontiers in cell and developmental biology
Published: March 19, 2020
mRNA as a Novel Treatment Strategy for Hereditary Spastic Paraplegia Type 5.
Journal: Molecular therapy. Methods & clinical development
Published: September 02, 2019
Decreased Na+/K+ ATPase Expression and Depolarized Cell Membrane in Neurons Differentiated from Chorea-Acanthocytosis Patients.
Journal: Scientific reports
Published: July 04, 2019
Generation of an induced pluripotent stem cell line from a patient with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP): HIHCNi003-A.
Journal: Stem cell research
Published: April 23, 2018
Establishment of STUB1/CHIP mutant induced pluripotent stem cells (iPSCs) from a patient with Gordon Holmes syndrome/SCAR16.
Journal: Stem cell research
Published: January 29, 2018
Hereditary spastic paraplegia type 5: natural history, biomarkers and a randomized controlled trial.
Hereditary spastic paraplegia type 5: natural history, biomarkers and a randomized controlled trial.
Journal: Brain : a journal of neurology
Published: May 02, 2017
Induced pluripotent stem cells (iPSCs) derived from cerebrotendinous xanthomatosis (CTX) patient's fibroblasts carrying a R395S mutation.
Journal: Stem cell research
Published: September 07, 2016
Last Updated: 09/26/2026